𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Labelling of a potent glucagon receptor antagonist with tritium, carbon-14 and stable isotopes

✍ Scribed by Steen K. Johansen; Sussi H. Wagner; Claus U. Jessen; Jacob S. Valsborg; Lars Martiny

Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
79 KB
Volume
50
Category
Article
ISSN
0022-2135

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Labelling of the guanylate cyclase activ
Labelling of the guanylate cyclase activator cinaciguat (BAY 58-2667) with carbon-14, tritium and stable isotopes
✍ D. Seidel; U. Pleiß 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB

## Abstract For studies of pharmacokinetics and drug metabolism of the new soluble guanylate cyclase activator cinaciguat (BAY 58‐2667) the ^14^C‐labelled compound was synthesized. The tritiated compound was required to elucidate the mode of action and the stable labelled compound was required for

Synthesis of carbon-14 and stable isotop
Synthesis of carbon-14 and stable isotope labelled NN414: a potent potassium channel opener
✍ Steen K. Johansen; Jesper B. Kristensen; Lars K. Müller; Claus U. Jessen; Christ 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 133 KB

## Abstract Currently, NN414, a potent __β__‐cell selective potassium channel opener, is undergoing clinical trials for the treatment of type 2 diabetes. Here, we report the synthesis of carbon‐14 and stable isotope labelled NN414 for use in metabolic studies and as an internal standard in pharmaco

Synthesis of deuterium-, tritium-, and c
Synthesis of deuterium-, tritium-, and carbon-14-labeled BILN2061, a potent hepatitis C virus protease inhibitor
✍ Bachir Latli; Matt Hrapchak; Vida Gorys; Carl A. Busacca; Chris Senanayake 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB

Hepatitis C virus (HCV) serine protease is a target for antiviral therapy against HCV infection, a leading cause of liver transplantation in the US. BILN2061, (1S, 4R, 6S, 7Z, 14S, 18R)-14-cyclopentyloxycarbonylamino-18-[2-(2-isopropylamino-thiazol-4-yl)-7-methoxyquinolin-4-yloxy]-2,15-dioxo-3,16-di

Model reactions targeted at the synthesi
Model reactions targeted at the synthesis of carbon-14 labeled CI-996, a potent antagonist of angiotensin II receptor (1)
✍ I. Victor Ekhato; Che C. Huang 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 361 KB 👁 1 views

## Abstract A reaction sequence suitable for the preparation of an analog of 2‐propyl‐1‐[2′‐(1H‐tetrazol‐5‐yl)[1,1′‐biphenyl]‐4‐yl]methyl‐4‐[2‐(trifluoroacetyl)‐1H‐pyrrol‐1‐yl]‐1H‐imidazole‐5‐carboxylic acid, with ^14^C at the methylene bridge was developed. The would‐be labeled fragment (12) was d

Synthesis of tritium and carbon-14 label
Synthesis of tritium and carbon-14 labelled NNC 61-4655: a potent dual-acting PPARα and PPARγ agonist
✍ Steen K. Johansen; Lars Martiny 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 119 KB

## Abstract The synthesis of the potent dual‐acting PPARα and PPARγ agonist NNC 61‐4655 labelled with tritium and carbon‐14 is reported. Tritium labelled NNC 61‐4655 was obtained in three steps with introduction of tritium through catalytic tritium‐halogen exchange of an aryl bromide precursor. Thi